Well done, always great to see new contracts with new clients.
MIYA observations (aka patientrak) is our most ‘validated’ product in terms of the research/evidence base on benefits, which might explain the consistent uptake in the UK and now Scotland. I’m really keen to see more cross selling opportunities across the MIYA suite come to fruition in the next 6-12 months.
Ann: Alcidion signs Miya Observations agreement with NHS Tayside, page-10
Add ALC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.005(8.47%) |
Mkt cap ! $85.91M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.4¢ | 6.0¢ | $47.18K | 769.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 474817 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 170435 | 4 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.1¢ | 6.2¢ | 6.0¢ | 385086 | ||
| Last updated 15.56pm 15/05/2024 ? | |||||
| ALC (ASX) Chart |